70.7 F
Pakistan
Thursday, June 4, 2026
HomeHealthNewLimit develops age-reversing drug, human clinical trial set for 2027

NewLimit develops age-reversing drug, human clinical trial set for 2027

NewLimit develops age-reversing drug, human clinical trial set for 2027NewLimit has come up with a new anti-aging breakthrough by developing a drug that can reverse the aging in human cells. Founded by Brian Armstrong, the company has closed a $435 million Series C funding round led by Founders. ..

Read full story on The News International

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments